We are live on
!
Find out more
GW & Wade Portfolio holdings
AUM
$3.08B
Turnover
13.09%
1-Year Est. Return
18.99%
This Fund
S&P 500
This Quarter
Est. Return
+12.36%
1 Year Est. Return
+18.99%
3 Year Est. Return
+32.19%
5 Year Est. Return
+95.75%
10 Year Est. Return
+162.41%
AUM
$1.06B
AUM Growth
+$133M
(+14%)
Cap. Flow
+$24.5M
Cap. Flow
% of AUM
2.31%
Top 10 Holdings %
Top 10 Hldgs %
33.76%
Holding
242
New
23
Increased
118
Reduced
51
Closed
13
Avg Time Held
3.3
years
Top 10 Avg Time Held
3.2
years
Top 20 Avg Time Held
3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$7.63M |
| 2 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$6.45M |
| 3 |
Vodafone
VOD
|
+$4.75M |
| 4 |
Amgen
AMGN
|
+$4.43M |
| 5 |
AT&T
T
|
+$4.35M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$12.8M |
| 2 |
Apple
AAPL
|
+$4.97M |
| 3 |
Vanguard Total Bond Market
BND
|
+$3.47M |
| 4 |
WisdomTree US LargeCap Dividend Fund
DLN
|
+$3.17M |
| 5 |
iShares Preferred and Income Securities ETF
PFF
|
+$1.32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 40.86% |
| 2 | Technology | 11.52% |
| 3 | Industrials | 9.21% |
| 4 | Energy | 8.28% |
| 5 | Financials | 6.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
Vanguard Morningstar Value ETF
VTV
$190B
| $259K | 0.02% |
+2,408
| New | +$254K |
2019 Q1
0 quarters
|
|
202
iShares Gold Trust
IAU
$61.7B
| $256K | 0.02% |
10,345
| – | – |
2018 Q4
1 quarter
|
|
|
ABMD
203
DELISTED
Abiomed Inc
ABMD
| $252K | 0.02% |
883
| – | – |
2018 Q1
4 quarters
|
|
204
Citizens Financial Group
CFG
$26.6B
| $249K | 0.02% |
7,648
+118
| +2% | +$4.09K |
2018 Q1
4 quarters
|
|
205
State Street Health Care Select Sector SPDR ETF
XLV
$45.7B
| $240K | 0.02% |
2,615
| – | – |
2017 Q2
7 quarters
|
|
206
UnitedHealth
UNH
$361B
| $239K | 0.02% |
+967
| New | +$247K |
2019 Q1
0 quarters
|
|
207
Valley National Bancorp
VLY
$7.01B
| $234K | 0.02% |
24,442
| – | – |
2017 Q1
8 quarters
|
|
208
State Street SPDR S&P Dividend ETF
SDY
$21.4B
| $233K | 0.02% |
+2,343
| New | +$225K |
2019 Q1
0 quarters
|
|
209
iShares MSCI Emerging Markets ETF
EEM
$29.2B
| $227K | 0.02% |
5,299
-1,442
| -21% | -$60.7K |
2018 Q2
3 quarters
|
|
210
Vanguard Dividend Appreciation ETF
VIG
$113B
| $219K | 0.02% |
+1,994
| New | +$210K |
2019 Q1
0 quarters
|
|
211
iShares Biotechnology ETF
IBB
$10.3B
| $218K | 0.02% |
1,953
-300
| -13% | -$32.9K |
2017 Q1
8 quarters
|
|
|
RDS.A
212
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $218K | 0.02% |
3,485
+13
| +0.4% | +$804 |
2018 Q1
4 quarters
|
|
213
WisdomTree International AI Enhanced Value Fund
AIVI
$60.5M
| $217K | 0.02% |
5,280
| – | – |
2017 Q1
8 quarters
|
|
214
Phillips 66
PSX
$117B
| $212K | 0.02% |
+2,230
| New | +$212K |
2019 Q1
0 quarters
|
|
215
Dominion Energy
D
$56B
| $211K | 0.02% |
+2,756
| New | +$201K |
2019 Q1
0 quarters
|
|
216
Fiserv Inc
FISV
$25.2B
| $211K | 0.02% |
+2,391
| New | +$197K |
2019 Q1
0 quarters
|
|
217
Axon Enterprise
AXON
$32.1B
| $209K | 0.02% |
+3,835
| New | +$197K |
2019 Q1
0 quarters
|
|
218
New England Realty Associates
NEN
$173M
| $208K | 0.02% |
+3,187
| New | +$190K |
2019 Q1
0 quarters
|
|
219
iShares Global Healthcare ETF
IXJ
$4.51B
| $202K | 0.02% |
+3,310
| New | +$197K |
2019 Q1
0 quarters
|
|
|
PBCT
220
DELISTED
People's United Financial Inc
PBCT
| $190K | 0.02% |
11,569
| – | – |
2015 Q1
16 quarters
|
|
221
Ford
F
$49.8B
| $166K | 0.02% |
18,856
+905
| +5% | +$7.77K |
2016 Q2
11 quarters
|
|
|
CNST
222
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $166K | 0.02% |
+12,262
| New | +$110K |
2019 Q1
0 quarters
|
|
223
Hewlett Packard
HPE
$73.4B
| $157K | 0.01% |
10,151
-557
| -5% | -$8.58K |
2018 Q1
4 quarters
|
|
224
Eaton Vance Limited Duration Income Fund
EVV
$960M
| $139K | 0.01% |
10,994
| – | – |
2015 Q1
16 quarters
|
|
225
SiriusXM
SIRI
$9.03B
| $111K | 0.01% |
1,960
| – | – |
2015 Q1
16 quarters
|
|
Similar funds
CC
PMEF
GC
WP
BWM
DI
GW & Wade's Q1 2019 Portfolio in Review
As of Q1 2019, GW & Wade held 242 positions worth $1.06B, up 14% from $925M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
GW & Wade's Q1 2019 filing shows 23 new, 118 increased, 51 reduced and 13 closed positions. Its largest new stake was Inovalon Holdings, Inc. Class A Common Stock: 60,000 shares worth $746K. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $12.8M.
By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, down from 44% a quarter earlier, followed by Technology and Industrials.
- GW & Wade's largest Q1 2019 buy was Inovalon Holdings, Inc. Class A Common Stock: 60,000 shares worth $746K.
- GW & Wade added most to Accenture in Q1 2019, an estimated $7.63M increase.
- GW & Wade's biggest Q1 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $12.8M.
- GW & Wade fully exited Vanguard S&P 500 ETF in Q1 2019, selling an estimated $728K.
- GW & Wade's ten largest holdings make up 34% of its $1.06B portfolio in Q1 2019.
- GW & Wade opened 23 new positions and closed 13 in Q1 2019.
- GW & Wade's portfolio value rose 14% quarter-over-quarter to $1.06B.
Based on GW & Wade's 13F filing for Q1 2019, filed 9 May 2019.